Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis

In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Hong Sang, Kim, Joon Ho, Woo, Myoung Lyeol, Kim, Ji-Yeon, Park, Chul Hee, Won, Hyejin, Lim, Seungkwan, Jeong, Hyeonju, Ham, Sin Young, Kim, Eun Jin, Sheen, Seungsoo, Kang, Yu Min, Yoon, Doran, Lee, Seung Youp, Song, Kyoung-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731255/
https://www.ncbi.nlm.nih.gov/pubmed/34951530
http://dx.doi.org/10.3947/ic.2021.0077
Descripción
Sumario:In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities in Gyeonggi province, Korea, were identified out of which the epidemiologic and clinical information of 66 asymptomatic patients at the time of diagnosis were analyzed retrospectively. An exposure-diagnosis interval within 7 days and abnormal aspartate aminotransferase levels were identified as characteristic symptom development in asymptomatic COVID-19 patients. If asymptomatic patients without these characteristics at the time of diagnosis could be differentiated early, more medical resources could be secured for mild or moderate cases in this COVID-19 surge.

Ejemplares similares